Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.4900 (-7.88%) ($25.2500 - $27.9000) on Thu. Apr. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.39% (three month average) | RSI | 70 | Latest Price | $25.4900(-7.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.195% in a week (0% probabilities). VXX(-12%) VIXM(-8%) TLT(-4%) UUP(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.195% (StdDev 4.39%) | Hourly BBV | 0 () | Intraday Trend | -7.9% | | | |
|
5 Day Moving Average | $26.91(-5.28%) | 10 Day Moving Average | $26.36(-3.3%) | 20 Day Moving Average | $25.06(1.72%) | To recent high | -7.9% | To recent low | 31.2% | Market Cap | $1.583b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |